Researchers Engineer Lysins to Target Bacteria With Surgical Precision
05 December 2020
Researchers have devised a method to produce customizable engineered lysins capable of selectively killing bacteria without harming surrounding ones, according to a press release shared with Interesting Engineering via email.
This could be a revolutionary medical development of an exciting possible alternative to antibiotics in treating drug-resistant bacteria and bacterial infections, without unwittingly strengthening bacterial resistance and putting lives at risk.
Further reading: Interesting Engineering
Author(s): Brad Bergan
Smart Innovations
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
